Pharmaceuticals, Biotechnology and Life Sciences
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that…
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today…
VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) — Segra International (“Segra”), a global leader in cannabis agriculture technology, proudly…
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency…
TrialWire™ is the risk-share pay-per-enrolled AI and algorithm-powered patient recruitment Platform built on Salesforce Health Cloud for industry-leading patient data…
Cash runway into Q3 2026AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout…
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated…
REDWOOD CITY, Calif., May 20, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics…
Oslo, 20 May 2025. PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) issue this notification on behalf of Hans…
Company now exclusively focused on the growing fertility market following the April 2025 announcement to divest a majority stake in…